Thank you. We've had a three-year programme. So, the programme was set up in 2019. We had a slight pause on the programme on the onset of the pandemic, but then, I think it must have been in between the first and second waves, we actually accelerated the cancer programme and made sure that that was a priority for us and for colleagues across Wales and particularly Velindre cancer centre. So, we successfully replaced the functionality that Velindre cancer centre were using in November 2022. That's been replaced with functionality developed and expanded on in our Welsh patient administration system. That manages pathways and, particularly, has been enhanced to manage the detailed information you want to track in a cancer pathway, and also upgraded our Welsh clinical portal, which is the clinician view of patient records, so that patient-centric view. That's been updated to record more of the clinical information along the pathway. Also, between the two systems, we've upgraded them to develop the multidisciplinary team meeting, so to manage the process of the discussions that are happening at MDT and then to collect all of the data that's needed then. There's quite a lot of data that is needed to be collected at those points. So, that functionality is available now. Two of the MDTs have gone live with that across Wales—so, that was breast and urology—the rest are being worked through in terms of the roll-out, because there's quite significant service change. Apologies. Sorry, we've got sensors on the lights. [Laughter.] Yes, looking after the pennies. There's quite significant service change within the local organisations, and, actually, the cancer teams want to do that as one across Wales. So, that roll-out is happening now throughout the next months.
There are improvements, and we've been continuing improvements with the Velindre cancer centre, which was a really successful implementation, considering that CaNISC had been their home-grown system for 20, possibly almost 30, years. So, it was in the DNA of all of their processing in the cancer centre, so that was a significant service change for the organisation, and it was, really, clinically and operationally led with all of the digital team supporting them, so really successful.
We've been continuing to work with them to improve, and then the other phases that we needed to work through—. That was phase 1. Phase 2 was the palliative care—so, how we support it, because cancer was supporting palliative care—so, we've got developments that are under way there now. Some are into testing, some further will be going into testing in September. And then we've got screening and colposcopy, which, I'll be honest, need quite a lot of work for us to do to take those things forward. But it's all being managed under the cancer programme.
We are working with the Welsh Government and the health boards in terms of the longevity of funding. We've got digital priority investment fund funding to support this until the end of March next year. There will be more work that we'll need to do, and, clearly, we will need sustainable funding in place, and we're working with the system on that, because the last thing I want is that we would have another CaNISC, where you have a system that's not being actively developed and becomes obsolete and unsupported. So, we are ensuring that we have the teams and the processes in place so that we can continue to grow and develop the system, to be honest, and listen to users and make sure that it can respond to their needs and it is useful and helps to support cancer pathways.